Buy
0
Hold
0
Sell
0
Watch
1
Mentions Over Time
last 3 months Buy Sell Hold Watch|Prediction trendFactual trend
Predictions and Factualities (1)
watch2027 to 2028Jun 8, 2026Confidence: 30%
Sponsored segment. CNXU is a pre-clinical stage regenerative tissue company with a patented CXU platform targeting wound care, aesthetics, dental, veterinary, and 3D bioprinting markets (combined $20B+ TAM). Pursuing a 510K regulatory pathway with wound care submission targeted for Q1 2027. Charlie presents the company for due diligence purposes only.
Horizon: long term
